MARKET

JNJ

JNJ

Johnson & Johnson
NYSE
209.30
-4.87
-2.27%
After Hours: 209.70 +0.4 +0.19% 19:59 12/16 EST
OPEN
214.00
PREV CLOSE
214.17
HIGH
214.73
LOW
208.81
VOLUME
9.95M
TURNOVER
--
52 WEEK HIGH
215.19
52 WEEK LOW
136.50
MARKET CAP
504.27B
P/E (TTM)
20.20
1D
5D
1M
3M
1Y
5Y
1D
Dow's 370-point fall led by losses in shares of IBM, Merck
MarketWatch · 11h ago
2 Recession-Proof Stocks to Watch in December
NASDAQ · 16h ago
Johnson & Johnson: Quality Compounding, Valuations Now Do The Heavy Lifting
Seeking Alpha · 20h ago
Johnson & Johnson (JNJ): Evaluating Valuation After FDA Approval of Akeega Prostate Cancer Therapy
Simply Wall St · 1d ago
Press Release: Johnson & Johnson to Host Investor Conference Call on Fourth-Quarter Results
Dow Jones · 1d ago
Notable Monday Option Activity: BBY, JNJ, AMC
NASDAQ · 1d ago
AC Immune: Maintaining 'Buy' Rating On Next Steps For ACI-7104.056 Development In PD
Seeking Alpha · 1d ago
Johnson & Johnson Gets Target Hike, But BofA Flags Modest Pipeline Impact
Benzinga · 1d ago
More
About JNJ
Johnson & Johnson and its subsidiaries are engaged in the research and development, manufacture, and sale of a range of products in the healthcare field. The Company’s segments include Innovative Medicine and MedTech. The Innovative Medicine segment is focused on various therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, cardiovascular and metabolism. Its products include REMICADE (infliximab), SIMPONI (golimumab), SIMPONI ARIA (golimumab), STELARA (ustekinumab), TREMFYA (guselkumab), EDURANT (rilpivirine), and INVEGA SUSTENNA/XEPLION (paliperidone palmitate). The MedTech segment includes a portfolio of products used in cardiovascular, orthopedics, surgery, and vision categories. The Cardiovascular portfolio includes electrophysiology products to treat heart rhythm disorders and circulatory restoration products (Shockwave) for the treatment of calcified coronary artery disease (CAD) and peripheral artery disease (PAD).

Webull offers Johnson & Johnson stock information, including NYSE: JNJ real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, JNJ stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading JNJ stock methods without spending real money on the virtual paper trading platform.